Factors that predict the occurrence of a surgical site infection due to methicillin-resistant Staphylococcus aureus (MRSA) are not well known; however this information could be used to modify the recommended antimicrobial prophylaxis. We carried out a retrospective study of S. aureus infections on orthopedic implants to determine: (1) whether epidemiological factors can be identified that predict a MRSA infection, (2) the impact of these factors as evidenced by the odds ratio (OR). Hypothesis: Risk factors for a MRSA infection can be identified from a cohort of patients with S. aureus infections. Materials and methods: We identified 244 patients who experienced a S. aureus surgical site infection (SSI) in 2011-2012 documented by intraoperative sample collection. Of these 244 patients, those who had a previous SSI (n = 44), those with a SSI but no orthopedic implant (n = 80) or those who had the infection more than 1-year after the initial surgery (n = 5) were excluded. This resulted in 115 patients (53 arthroplasty, 62 bone fixation) being analyzed for this study. There were 24 MRSA infections and 91 MSSA infections. The following factors were evaluated in bivariate and multifactorial analysis: age, sex, type of device (prosthesis/bone fixation), predisposition (diabetes, obesity, kidney failure), and environmental factors (hospitalization in intensive care unit within past 5 years, nursing home stay). Results: Two factors were correlated with the occurrence of MRSA infections. (1) Nursing home patients had a higher rate of MRSA infections (67% vs. 18%, P = 0.017) with an OR of 8.42 (95% CI: 1.06-66.43).
Introduction
Staphylococcus aureus is responsible for a large number of different infectious conditions, ranging from colonization to septic shock [1] . The first methicillin-resistant S. aureus (MRSA) infections appeared in 1961. They are typically associated with a high We performed a retrospective study to identify epidemiological factors predictive of a potential MRSA infection that could make it possible to adapt the antimicrobial prophylaxis in certain patients groups, without having to implement systematic screening. We hypothesized that risk factors for a MRSA infection could be identified from a cohort of patients with S. aureus infections. The primary objective of this study was to identify predictors of MRSA infections in patients undergoing total joint arthroplasty or fracture fixation. The secondary objective was to quantify each factor's impact by calculating the odds ratio (OR).
Materials and methods

Patients
We performed a retrospective epidemiological study of S. aureus infection cases in 2011 and 2012. Included were patients reoperated early on (<1-year) because of a surgical site infection (SSI) secondary to primary implantation of an orthopedic device (prosthesis or fracture fixation) and for which intraoperative microbiological samples were positive for S. aureus. Excluded were patients who did not receive an orthopedic implant and patients who had already received treatment for a systemic or surgical site infection that could affect the bacterial flora. All patients had received the same intraoperative antimicrobial prophylaxis (cephazolin).
Population
Of the 244 identified patients, 80 were excluded because they did not receive an orthopedic implant (48 soft tissue infections, 15 osteitis, 17 arthritis). In 44 patients (20 prosthesis, 24 fracture fixation), the pathogen was already known at the time of treatment. They were excluded because they had already been treated (surgery + antibiotics). Five other patients who underwent arthroplasty suffered an infection more than 1-year after the initial procedure, and were not included. This resulted in 115 patients being analyzed for this study (Fig. 1) . There was no missing data.
We used the Molis V3/V4 computer system (Vision4health, Paris, France) at the Microbiology Institute of the Lille University Hospital to retrieve information about the cases of S. aureus infection over this 2-year period. Microbiological samples had been collected intraoperatively in all patients.
The strains were determined using the laboratory's protocol in standard or enriched (Rosenow's broth) media. Microbial identification and antibiotic susceptibility testing were performed with the automated VITEK2 device (Biomérieux, Marcy l'Etoile, France). The results were interpreted in accordance with recommendations of the antibiogram committee of the French Microbiology Society.
Assessment methods
The following factors were evaluated: methicillin resistance, age at time of diagnosis, sex, medical history (diabetes, obesity, kidney failure), open fracture at time of initial surgery. We also recorded any instances of the patient being hospitalized in the intensive care unit (ICU) in the prior 5 years or in a nursing home.
Data was collected after systematic review of the patient records; calls were made to the patients if there was any missing data. Patients were labeled as obese if their BMI was over 30, in kidney failure if their creatinine clearance during the preoperative blood work-up was less than 89 mL/min, and diabetic if their fasting blood sugar was above 1.26 mg/L. 
Statistical methods
The statistical analysis was carried out with SAS software (version 9.3, SAS Institute, Cary, USA). The statistical tests were performed with a type I risk of 5%. The results were expressed as frequencies and percentages for the qualitative variables and mean ± standard deviation for age at the time of diagnosis (the only quantitative variable in this study). Potential predictors of a MRSA infection were first studied with bivariate tests. Qualitative variables were compared between patients with and without MRSA infection using Chi-squared or Fisher's exact test (if expected frequencies are less than 5); the age at diagnosis was compared using Student's t-test. A multivariate analysis was performed with all the variables having significance below 0.20 in the bivariate analyses, using an exact logistic regression model. A sensitivity analysis was performed after excluding potential confounding factors to validate our findings.
Results
Characteristics of the patient cohort
Patients were 60 years of age on average at the time of diagnosis (range 3-91, SD: 19.2) and 58% were women. MRSA infection was found in 24 patients, a rate of 21% (95% CI: 13.4-28.3). Fifty-three patients had received a prosthesis (24 total knee arthroplasty, 27 total hip arthroplasty, 2 total shoulder arthroplasty) and 62 had undergone bone fixation. Ten of the 27 hip arthroplasty procedures had been performed in an emergency context. Of the 17 patients with an open fracture, 10 had a Cauchoix-Duparc type I opening, three had type II and four had type III.
Among of the 14 patients who had been in ICU in the 5 years before the SSI, seven were in the ICU because the initial trauma required surgical care. Nineteen patients had diabetes, all type 2 diabetes.
All the patients who underwent a surgical procedure were hospitalized in the orthopedics unit and received antimicrobial prophylaxis with the device implantation.
Predictors of MRSA infection
In the bivariate analysis, only a nursing home stay and fracture fixation were significantly associated with MRSA infection (Table 1) .
Nursing home patients had a higher MRSA infection rate than the other patients (67% vs. 18%, P = 0.017). Patients who had undergone fracture fixation had a lower MRSA infection rate than patients who had undergone arthroplasty (13% vs. 30%, P = 0.023). The MRSA infection rate was not higher in patients who had an open fracture (35% vs. 18%, P = 0.11) or in older patients (mean ± SD: 65.2 ± 20.5 vs 58.6 ± 18.6, P = 0.13). There was no significant difference in the MRSA infection rate between patients who underwent total hip arthroplasty because of trauma and those who underwent a scheduled procedure (54% vs 38% P = 0.15).
In the multivariate analysis, only the nursing home stay and fracture fixation were still statistically associated with MRSA infection; the OR was 8.4 (95% CI: 1.06-66.43) for nursing home patients and 0.1 (95% CI: 0.02-0.56) for patients who underwent fracture fixation. Open fractures were also significantly associated with MRSA infection with an OR of 11.5 (95% CI: 1.98-67.38). Since all four kidney failure patients had a MRSA infection, we carried out a sensitivity analysis excluding these four patients; the findings were the same ( 
Discussion
Our study showed that risk factors that can easily be identified before the surgery-nursing home stay, arthroplasty, open fracture-should raise the suspicions of a possible MRSA infection and trigger a discussion about antimicrobial prophylaxis against MRSA. Surgical site infection is one of the main reasons for revision [9] . It occurs in 0.7-3.6% of arthroplasty procedures [9] [10] [11] [12] and 0.4-16.1% of fracture fixation procedures [13, 14] .
Various studies have looked into methods to prevent MRSA infections, including systematic screening, isolation and antimicrobial prophylaxis [7, [15] [16] [17] . Biant et al. [15] reported an overall reduction in MRSA infections by isolating at-risk patients, but this is not always realistic [7] . The systematic screening recommended by Coia et al. [7] is controversial, given that 3.2-7.2% of patients in orthopedic and trauma units are MRSA carriers [5, 16] . While it is accepted that MRSA carriage implies a greater risk of MRSA infections [5, 18] , some teams have questioned the usefulness of screening and its cost [16, 18, 19] . The main measure for preventing SSIs remains antimicrobial prophylaxis. The American Academy of Orthopedic Surgeons recommends using cefazolin or cefuroxime as antimicrobial prophylaxis for arthroplasty procedures, and adding vancomycin if the patient is a MRSA carrier [20] . Vancomycin is not better at preventing SSIs [21] but it reduces the MRSA infection rate [17, 21] . Sewick et al. [17] estimated that 138 patients need to be treated with vancomycin to prevent one MRSA infection. This number must be taken into consideration when evaluating the risk-benefit ratio, since this antibiotic has side effects that are not insignificant (e.g., acute renal failure, ototoxicity, development of resistance).
Our study has several limitations, the main one being its retrospective nature, which can induce a patient selection bias. We reduced this bias by using a continuous cohort of all patients who had a S. aureus infection over a 2-year period. Another limitation of our study is due to the small number of included patients. We cannot exclude the fact that some differences may not have been found because of low statistical power, making our findings less robust. Higher power would have allowed us to look at the prevalence of MRSA infections for each type of implant used, thereby making our results more specific. Sixty-seven percent of the nursing home patients infected during the study period had a MRSA infection. This is comparable with published studies reporting colonization in 7.1-28.8% of nursing home patients responsible for more common MRSA infections [22, 23] . This rate can be explained by the many hospitalizations, number of permanent devices and frequent antibiotic treatment given to these patients. Our findings, with an OR of 8.4 (95% IC: 1.06-66.43), could drive a change in the antimicrobial prophylaxis with systemic use of a glycopeptide in this patient group; however additional studies are needed to evaluate the risk-benefit ratio in these elderly patients.
Patients who underwent fracture fixation had a lower risk of MRSA infections than those who underwent arthroplasty with an OR of 0.11 (95% CI: 0.02-0.56). To our knowledge, no other study has compared the MRSA infection rate in these two patient groups, and we have no explanation for this difference. These two groups were different in terms of potentially confounding variables, as shown in Table 2 . The prosthesis group had older patients (average: 70 years vs. 52 years), patients with more co-morbidities and in particular, more nursing home patients. Conversely, 27.4% of patients in the fracture group had an open wound at the time of surgery versus 0% in the prosthesis group. It is difficult to assess the causality of each factor in these two groups.
Open fractures typically have a higher infection risk with an incidence of 3.7-19% [24, 25] . To our knowledge, no other study has compared the MRSA infection rate in patients who had or did not have an open wound at the time of the primary surgery. Our study found an increased MRSA infection rate in patients with an open wound at the surgical site, with an OR of 11.5 (95% CI: 1.98-67.38). Lastly, all patients with kidney failure (n = 4) had a MRSA infection, but the sample size was too small to perform any statistical testing on this sub-group. We cannot draw any conclusions based on this finding, although it is consistent with published data: kidney failure patients, particularly those undergoing dialysis, are more often carriers of MRSA responsible for the most common bacterial infections [23, 26] .
Other known risk factors for MRSA infection such as the use of antibiotics in the prior year [23] and recent hospitalization [23, 27] were not evaluated in our study because all the patients had these two risk factors.
Conclusion
Patients who resided at a nursing home, who had an open fracture and/or underwent arthroplasty were most often positive for MRSA when they had a S. aureus infection. Now that these at-risk groups have been defined, it would be interesting to perform a randomized study to determine the prevalence of MSSA and MRSA infections between a group of patients receiving standard antimicrobial prophylaxis and another receiving second-generation cephalosporin with vancomycin. This type of study would allow us to assess the prevalence of MSSA and MSRA infections in our patients and to quantify the risks and benefits of systematic vancomycin use.
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